Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.

The global Personalized Cancer Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Personalized Cancer Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Personalized Cancer Medicine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Personalized Cancer Medicine in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Personalized Cancer Medicine include Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas and Astrazeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Personalized Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Cancer Medicine.

Report Scope

The Personalized Cancer Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personalized Cancer Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalized Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Personalized Cancer Medicine Market Report

Report Metric	Details
Report Name	Personalized Cancer Medicine Market
Segment by Type	Monoclonal Antibodies Personalized Cancer Vaccines Other
Segment by Application	Breast Cancer Lung Cancer Chronic Myeloid Leukaemia Bowel Cancer Other Cancer
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas, Astrazeneca, Johnson & Johnson, Agilent, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Cancer Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Personalized Cancer Medicine Market report?

Ans: The main players in the Personalized Cancer Medicine Market are Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas, Astrazeneca, Johnson & Johnson, Agilent, Takeda

What are the Application segmentation covered in the Personalized Cancer Medicine Market report?

Ans: The Applications covered in the Personalized Cancer Medicine Market report are Breast Cancer, Lung Cancer, Chronic Myeloid Leukaemia, Bowel Cancer, Other Cancer

What are the Type segmentation covered in the Personalized Cancer Medicine Market report?

Ans: The Types covered in the Personalized Cancer Medicine Market report are Monoclonal Antibodies, Personalized Cancer Vaccines, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Personalized Cancer Vaccines

1.2.4 Other

1.3 Market by Application

1.3.1 Global Personalized Cancer Medicine Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Breast Cancer

1.3.3 Lung Cancer

1.3.4 Chronic Myeloid Leukaemia

1.3.5 Bowel Cancer

1.3.6 Other Cancer

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Personalized Cancer Medicine Market Perspective (2019-2030)

2.2 Personalized Cancer Medicine Growth Trends by Region

2.2.1 Global Personalized Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Personalized Cancer Medicine Historic Market Size by Region (2019-2024)

2.2.3 Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030)

2.3 Personalized Cancer Medicine Market Dynamics

2.3.1 Personalized Cancer Medicine Industry Trends

2.3.2 Personalized Cancer Medicine Market Drivers

2.3.3 Personalized Cancer Medicine Market Challenges

2.3.4 Personalized Cancer Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Personalized Cancer Medicine Players by Revenue

3.1.1 Global Top Personalized Cancer Medicine Players by Revenue (2019-2024)

3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Personalized Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Personalized Cancer Medicine Revenue

3.4 Global Personalized Cancer Medicine Market Concentration Ratio

3.4.1 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Medicine Revenue in 2023

3.5 Personalized Cancer Medicine Key Players Head office and Area Served

3.6 Key Players Personalized Cancer Medicine Product Solution and Service

3.7 Date of Enter into Personalized Cancer Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cancer Medicine Breakdown Data by Type

4.1 Global Personalized Cancer Medicine Historic Market Size by Type (2019-2024)

4.2 Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030)

5 Personalized Cancer Medicine Breakdown Data by Application

5.1 Global Personalized Cancer Medicine Historic Market Size by Application (2019-2024)

5.2 Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Personalized Cancer Medicine Market Size (2019-2030)

6.2 North America Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Personalized Cancer Medicine Market Size by Country (2019-2024)

6.4 North America Personalized Cancer Medicine Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Personalized Cancer Medicine Market Size (2019-2030)

7.2 Europe Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Personalized Cancer Medicine Market Size by Country (2019-2024)

7.4 Europe Personalized Cancer Medicine Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Personalized Cancer Medicine Market Size (2019-2030)

8.2 Asia-Pacific Personalized Cancer Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2019-2024)

8.4 Asia-Pacific Personalized Cancer Medicine Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Personalized Cancer Medicine Market Size (2019-2030)

9.2 Latin America Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Personalized Cancer Medicine Market Size by Country (2019-2024)

9.4 Latin America Personalized Cancer Medicine Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Personalized Cancer Medicine Market Size (2019-2030)

10.2 Middle East & Africa Personalized Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2019-2024)

10.4 Middle East & Africa Personalized Cancer Medicine Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott Personalized Cancer Medicine Introduction

11.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2019-2024)

11.1.5 Abbott Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck Personalized Cancer Medicine Introduction

11.2.4 Merck Revenue in Personalized Cancer Medicine Business (2019-2024)

11.2.5 Merck Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Personalized Cancer Medicine Introduction

11.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Amgen

11.4.1 Amgen Company Detail

11.4.2 Amgen Business Overview

11.4.3 Amgen Personalized Cancer Medicine Introduction

11.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2019-2024)

11.4.5 Amgen Recent Development

11.5 Celgene

11.5.1 Celgene Company Detail

11.5.2 Celgene Business Overview

11.5.3 Celgene Personalized Cancer Medicine Introduction

11.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2019-2024)

11.5.5 Celgene Recent Development

11.6 Bayer

11.6.1 Bayer Company Detail

11.6.2 Bayer Business Overview

11.6.3 Bayer Personalized Cancer Medicine Introduction

11.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2019-2024)

11.6.5 Bayer Recent Development

11.7 Roche

11.7.1 Roche Company Detail

11.7.2 Roche Business Overview

11.7.3 Roche Personalized Cancer Medicine Introduction

11.7.4 Roche Revenue in Personalized Cancer Medicine Business (2019-2024)

11.7.5 Roche Recent Development

11.8 Astellas

11.8.1 Astellas Company Detail

11.8.2 Astellas Business Overview

11.8.3 Astellas Personalized Cancer Medicine Introduction

11.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2019-2024)

11.8.5 Astellas Recent Development

11.9 Astrazeneca

11.9.1 Astrazeneca Company Detail

11.9.2 Astrazeneca Business Overview

11.9.3 Astrazeneca Personalized Cancer Medicine Introduction

11.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024)

11.9.5 Astrazeneca Recent Development

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Detail

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Personalized Cancer Medicine Introduction

11.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024)

11.10.5 Johnson & Johnson Recent Development

11.11 Agilent

11.11.1 Agilent Company Detail

11.11.2 Agilent Business Overview

11.11.3 Agilent Personalized Cancer Medicine Introduction

11.11.4 Agilent Revenue in Personalized Cancer Medicine Business (2019-2024)

11.11.5 Agilent Recent Development

11.12 Takeda

11.12.1 Takeda Company Detail

11.12.2 Takeda Business Overview

11.12.3 Takeda Personalized Cancer Medicine Introduction

11.12.4 Takeda Revenue in Personalized Cancer Medicine Business (2019-2024)

11.12.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Personalized Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Personalized Cancer Vaccines

Table 4. Key Players of Other

Table 5. Global Personalized Cancer Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Personalized Cancer Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Personalized Cancer Medicine Market Share by Region (2019-2024)

Table 9. Global Personalized Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Personalized Cancer Medicine Market Share by Region (2025-2030)

Table 11. Personalized Cancer Medicine Market Trends

Table 12. Personalized Cancer Medicine Market Drivers

Table 13. Personalized Cancer Medicine Market Challenges

Table 14. Personalized Cancer Medicine Market Restraints

Table 15. Global Personalized Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Personalized Cancer Medicine Market Share by Players (2019-2024)

Table 17. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)

Table 18. Ranking of Global Top Personalized Cancer Medicine Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Personalized Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Personalized Cancer Medicine Product Solution and Service

Table 22. Date of Enter into Personalized Cancer Medicine Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Personalized Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Personalized Cancer Medicine Revenue Market Share by Type (2019-2024)

Table 26. Global Personalized Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Personalized Cancer Medicine Revenue Market Share by Type (2025-2030)

Table 28. Global Personalized Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Personalized Cancer Medicine Revenue Market Share by Application (2019-2024)

Table 30. Global Personalized Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Personalized Cancer Medicine Revenue Market Share by Application (2025-2030)

Table 32. North America Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Personalized Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Personalized Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Personalized Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Personalized Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 47. Abbott Company Detail

Table 48. Abbott Business Overview

Table 49. Abbott Personalized Cancer Medicine Product

Table 50. Abbott Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 51. Abbott Recent Development

Table 52. Merck Company Detail

Table 53. Merck Business Overview

Table 54. Merck Personalized Cancer Medicine Product

Table 55. Merck Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 56. Merck Recent Development

Table 57. Novartis Company Detail

Table 58. Novartis Business Overview

Table 59. Novartis Personalized Cancer Medicine Product

Table 60. Novartis Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Amgen Company Detail

Table 63. Amgen Business Overview

Table 64. Amgen Personalized Cancer Medicine Product

Table 65. Amgen Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 66. Amgen Recent Development

Table 67. Celgene Company Detail

Table 68. Celgene Business Overview

Table 69. Celgene Personalized Cancer Medicine Product

Table 70. Celgene Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 71. Celgene Recent Development

Table 72. Bayer Company Detail

Table 73. Bayer Business Overview

Table 74. Bayer Personalized Cancer Medicine Product

Table 75. Bayer Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 76. Bayer Recent Development

Table 77. Roche Company Detail

Table 78. Roche Business Overview

Table 79. Roche Personalized Cancer Medicine Product

Table 80. Roche Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 81. Roche Recent Development

Table 82. Astellas Company Detail

Table 83. Astellas Business Overview

Table 84. Astellas Personalized Cancer Medicine Product

Table 85. Astellas Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 86. Astellas Recent Development

Table 87. Astrazeneca Company Detail

Table 88. Astrazeneca Business Overview

Table 89. Astrazeneca Personalized Cancer Medicine Product

Table 90. Astrazeneca Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 91. Astrazeneca Recent Development

Table 92. Johnson & Johnson Company Detail

Table 93. Johnson & Johnson Business Overview

Table 94. Johnson & Johnson Personalized Cancer Medicine Product

Table 95. Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 96. Johnson & Johnson Recent Development

Table 97. Agilent Company Detail

Table 98. Agilent Business Overview

Table 99. Agilent Personalized Cancer Medicine Product

Table 100. Agilent Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 101. Agilent Recent Development

Table 102. Takeda Company Detail

Table 103. Takeda Business Overview

Table 104. Takeda Personalized Cancer Medicine Product

Table 105. Takeda Revenue in Personalized Cancer Medicine Business (2019-2024) & (US$ Million)

Table 106. Takeda Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Personalized Cancer Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Personalized Cancer Medicine Market Share by Type: 2023 VS 2030

Figure 3. Monoclonal Antibodies Features

Figure 4. Personalized Cancer Vaccines Features

Figure 5. Other Features

Figure 6. Global Personalized Cancer Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Personalized Cancer Medicine Market Share by Application: 2023 VS 2030

Figure 8. Breast Cancer Case Studies

Figure 9. Lung Cancer Case Studies

Figure 10. Chronic Myeloid Leukaemia Case Studies

Figure 11. Bowel Cancer Case Studies

Figure 12. Other Cancer Case Studies

Figure 13. Personalized Cancer Medicine Report Years Considered

Figure 14. Global Personalized Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Personalized Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Personalized Cancer Medicine Market Share by Region: 2023 VS 2030

Figure 17. Global Personalized Cancer Medicine Market Share by Players in 2023

Figure 18. Global Top Personalized Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Cancer Medicine as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Personalized Cancer Medicine Revenue in 2023

Figure 20. North America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Personalized Cancer Medicine Market Share by Country (2019-2030)

Figure 22. United States Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Personalized Cancer Medicine Market Share by Country (2019-2030)

Figure 26. Germany Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Personalized Cancer Medicine Market Share by Region (2019-2030)

Figure 34. China Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Personalized Cancer Medicine Market Share by Country (2019-2030)

Figure 42. Mexico Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Personalized Cancer Medicine Market Share by Country (2019-2030)

Figure 46. Turkey Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Personalized Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 49. Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 50. Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 51. Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 52. Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 53. Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 54. Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 55. Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 56. Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 57. Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 58. Agilent Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 59. Takeda Revenue Growth Rate in Personalized Cancer Medicine Business (2019-2024)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pediatric Cardiac Tumor Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G6046

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Interventional Oncology Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20U7613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions